CHI3L1 and Alzheimer disease: CSF YKL-40 levels in patients with Alzheimer’s disease, after correcting for age, were found to be 27.7% and 38.8% lower in patients with dementia with Lewy bodies and Parkinson’s disease, respectively, compared with Alzheimer’s disease [197].